Yiran Liang

Jinan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

FBXW5 blunts RIGI/MDA5-IFN signaling to drive immunoevasion and chemo-immune resistance in triple-negative breast cancer models.

FBXW5 blunts RIGI/MDA5-IFN signaling to drive immunoevasion and chemo-immune resistance in triple-negative breast cancer models.

Journal: The Journal of clinical investigation
Published: August 25, 2026

Development and validation of a nomogram for predicting axillary reverse mapping lymph node metastasis in breast cancer patients.

Development and validation of a nomogram for predicting axillary reverse mapping lymph node metastasis in breast cancer patients.

Journal: Frontiers in oncology
Published: April 13, 2026

Non-histone lactylation in cancer: current advances and clinical implications.

Non-histone lactylation in cancer: current advances and clinical implications.

Journal: Frontiers in immunology
Published: March 06, 2026

Cancer-Associated Fibroblasts Promote Glucose Metabolic Reprogramming and Progression of Triple-Negative Breast Cancer via Exosomal circFAD104-Mediated Intercellular Communication.

Cancer-Associated Fibroblasts Promote Glucose Metabolic Reprogramming and Progression of Triple-Negative Breast Cancer via Exosomal circFAD104-Mediated Intercellular Communication.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 05, 2026

circZNF148 Drives Glucose Metabolism Reprogramming to Enhance Metastasis and Immune Evasion via HK1 Stabilization in Triple-Negative Breast Cancer.

circZNF148 Drives Glucose Metabolism Reprogramming to Enhance Metastasis and Immune Evasion via HK1 Stabilization in Triple-Negative Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 09, 2026

Oncotype DX: Clinical Utility, Evidence, and Future Trends in Personalized Breast Cancer Management.

Oncotype DX: Clinical Utility, Evidence, and Future Trends in Personalized Breast Cancer Management.

Journal: International journal of cancer
Published: December 21, 2025

Alternative splicing rewires breast cancer and opens therapeutic avenues.

Alternative splicing rewires breast cancer and opens therapeutic avenues.

Journal: Cell communication and signaling : CCS
Published: November 19, 2025

CircIQGAP1-CARM1 axis promotes renal cell carcinoma progression through glycolytic reprogramming.

CircIQGAP1-CARM1 axis promotes renal cell carcinoma progression through glycolytic reprogramming.

Journal: Cell death & disease
Published: October 15, 2025

CircNSD2 promotes metastasis and immune escape by increasing the USP10/SRSF6-mediated alternative splicing of TPM1 in TNBC.

CircNSD2 promotes metastasis and immune escape by increasing the USP10/SRSF6-mediated alternative splicing of TPM1 in TNBC.

Journal: Molecular cancer
Published: September 22, 2025

CircKIAA1617 promotes stemness via USP14/PGRMC1-mediated autophagy and lipid metabolism reprogramming in ER-positive breast cancer.

CircKIAA1617 promotes stemness via USP14/PGRMC1-mediated autophagy and lipid metabolism reprogramming in ER-positive breast cancer.

Journal: Molecular cancer
Published: September 09, 2025

Correction: COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk.

Correction: COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk.

Journal: Oncogene
Published: August 28, 2025

Postoperative radiotherapy for ductal carcinoma in situ: survival prediction and clinical decision support using a nomogram-based approach.

Postoperative radiotherapy for ductal carcinoma in situ: survival prediction and clinical decision support using a nomogram-based approach.

Journal: Scientific reports
Published: August 04, 2025
Showing 1-12 of 74

Last Updated: 09/26/2026